Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de novo Kidney Transplant Recipients
Shah, Malay
(PI)
Surgery
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
1/1/13
→
5/31/13
Funding
Astellas Pharma Global Development Incorporated:
$7,258.00
View all
View less